Nature Communications (Feb 2022)

Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis

  • Farshad Farshidfar,
  • Kahn Rhrissorrakrai,
  • Chaya Levovitz,
  • Cong Peng,
  • James Knight,
  • Antonella Bacchiocchi,
  • Juan Su,
  • Mingzhu Yin,
  • Mario Sznol,
  • Stephan Ariyan,
  • James Clune,
  • Kelly Olino,
  • Laxmi Parida,
  • Joerg Nikolaus,
  • Meiling Zhang,
  • Shuang Zhao,
  • Yan Wang,
  • Gang Huang,
  • Miaojian Wan,
  • Xianan Li,
  • Jian Cao,
  • Qin Yan,
  • Xiang Chen,
  • Aaron M. Newman,
  • Ruth Halaban

DOI
https://doi.org/10.1038/s41467-022-28566-4
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 16

Abstract

Read online

Despite acral melanoma being the most common melanoma subtype in non-White individuals, its molecular drivers remain unknown. Here, the authors integrate genomic and clinical data from 104 patients and identify late-arising focal amplifications of chr22q11.21 and LZTR1 as a key tumour promoter in this region.